CeriBell (CBLL) Revenue & Revenue Breakdown
CeriBell Revenue Highlights
Latest Revenue (Y)
$45.23M
Latest Revenue (Q)
$21.20M
Main Segment (Y)
Product
CeriBell Revenue by Period
CeriBell Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $45.23M | 74.47% |
| 2022-12-31 | $25.92M | - |
CeriBell generated $45.23M in revenue during NA 2023, up 74.47% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
CeriBell Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $21.20M | 3.46% |
| 2025-03-31 | $20.49M | 10.56% |
| 2024-12-31 | $18.53M | 7.79% |
| 2024-09-30 | $17.20M | 15.73% |
| 2024-06-30 | $14.86M | - |
| 2024-03-31 | $14.86M | 13.15% |
| 2023-12-31 | $13.13M | 13.09% |
| 2023-09-30 | $11.61M | 13.37% |
| 2023-06-30 | $10.24M | - |
| 2023-03-31 | $10.24M | - |
CeriBell generated $21.20M in revenue during Q2 2025, up 3.46% compared to the previous quarter, and up 142.68% compared to the same period a year ago.
CeriBell Revenue Breakdown
CeriBell Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 |
|---|---|
| Subscription | $15.37M |
| Product | $50.08M |
Latest
CeriBell's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (76.52%), and Subscription (23.48%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 |
|---|---|---|
| Product | $15.92M | $15.61M |
| Subscription | $5.28M | $4.88M |
Latest
CeriBell's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (75.11%), and Subscription (24.89%).
CeriBell Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SY | So-Young | $1.50B | $318.28M |
| VREX | Varex Imaging | $811.00M | $212.90M |
| AVNS | Avanos Medical | $687.80M | $175.00M |
| BVS | Bioventus | $573.28M | $147.66M |
| KIDS | OrthoPediatrics | $204.73M | $61.08M |
| PACB | Pacific Biosciences of California | $154.01M | $37.15M |
| ADCT | ADC Therapeutics | $69.28M | $17.40M |
| CBLL | CeriBell | $45.23M | $21.20M |
| CATX | Perspective Therapeutics | $1.43M | - |
| CGEM | Cullinan Therapeutics | - | - |
| FDMT | 4D Molecular Therapeutics | - | $14.00K |